# Jinling Hospital, China: Early phase 1 study in Pouchitis, UC - Ulcerative Colitis (12 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Jinling Hospital, China |
| Sponsor type | Academic and hospital |
| Study | Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC) |
| NCT ID | NCT07878026 |
| Phase | Early phase 1 |
| Status | not yet recruiting |
| Conditions | Pouchitis; UC - Ulcerative Colitis |
| Intervention types | biological |
| Target enrollment | 12 |
| Site countries | China |
| Posted | 2026-10-16 |
| Planned start | 2027-01-01 |
| Event | Newly registered study |
| Event date | 2026-10-16 |

## Why this score
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07878026). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.